Zealand Pharma stock soars after selling insulin pump
The biotech firm is recovering losses on the stock exchange after a sales agreement with Mannkind Corporation over insulin pump V-Go was announced on Tuesday.
by christian bundgaard, translated by daniel pedersen
According to the Danish Financial Supervisory Authority, Zealand Pharma is one of the most speculative stocks listed on the Copenhagen stock exchange, a practice also known as shorting.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma sells insulin pump to Mannkind Corporation
For subscribers
Zealand Pharma rescue pen books USD 0.6m revenue in Q1
For subscribers
.jpg&w=384&q=75)
